pharma news today obesity drugs glp-1 september 2025 The FDA approved a new pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication A network meta-analysis backed weight-loss
Description
Although 16 of the 30 amino acids in its N-terminus are identical to human GLP-1 (736) amide, exendin-4 is not the lizard homolog of GLP-1
Our goal is to create sustainable weight management strategies that prioritize patient safety and long-term success, ensuring each treatment is tailored to individual health needs
doi: 10.1038/s42255-022-00617-6 40 SachsSBastidas-PonceATritschlerSBakhtiMBottcherASanchez-GarridoMAet al
In NAFLD mice, liraglutide could improve the hypoadiponectinemia-induced inflammatory stress by inhibiting the MKK4/JNK signaling pathway, inhibit liver adipogenesis by activating AMPK, and induce autophagy through the AMPK/mTOR pathway, hence improving the levels of liver lipids (23, 198)
This realization shaped his future research direction
11 In clinical trials, exenatide has demonstrated efficacy in terms of both improved glycemic control and appetite suppression leading to weight loss
